Immunotherapy is a type of cancer treatment that helps a person’s immune system recognize and attack cancer cells.
The immune system detects and protects the body from anything it perceives as foreign, such as viruses, bacteria and even cells that are abnormal because they are cancerous. However, cancer has found ways to evade the immune system. Cancer immunotherapy is designed to help the immune system recognize cancer cells and activate specific immune cells to target and attack them. As a potential side effect, immunotherapy could cause the immune system to attack normal organs and tissue in the body.
There are now a number of new immunotherapies approved by the U.S. Food and Drug Administration (FDA) for certain people with a type of bladder cancer called locally advanced or metastatic urothelial carcinoma. Your doctor can help you determine if you might be a candidate for this treatment option.
Click here to read our Get the Facts | Immunotherapy (PDF) that covers what to expect before, during, and after this treatment.
Watch Questions & Answers about Immunotherapy and Bladder Cancer presented by Dr. Jonathan Rosenberg from Memorial Sloan-Kettering Cancer Center to learn more.
The information and services provides by the Bladder Cancer Advocacy Network (BCAN) are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. If you are ill, or suspect that you are ill, seek professional medical attention immediately! BCAN does not recommend or endorse any specific physicians, treatments, procedures or products even though they may be mentioned on this site.